Supplements and Featured Publications
2025 Year in Review: Non–Small Cell Lung Cancer
Volume: 31
2025 Year in Review: Idiopathic Pulmonary Fibrosis
Expert Consensus on Essential Characteristics of Oncology Value-Based Payment
The Evolving Role of Subcutaneous Therapies in EGFR+ NSCLC
2025 Year in Review: Lymphoma
The Economics of Atopic Dermatitis: From Real-World Burden to Value- Driven Treatment Strategies
2025 Year in Review: Clostridioides difficile Infection
Equitable Management of Atopic Dermatitis: Treatment Considerations Across Patient Populations
2025 Year in Review: Neurofibromatosis Type 1 With Plexiform Neurofibromas
Modernizing COPD Management: Guideline Evolution, Therapeutic Advances, and Practical Insights
Economic Impact of Intravenous Versus Subcutaneous Administration of Infliximab on Health System Finances and Operations
Managing HIV in 2025: Optimizing Treatment After Virologic Suppression
Exploring Emerging Therapies in Myasthenia Gravis
Clinical and Economic Considerations for Nivolumab-Based Therapy for Resectable Non–Small Cell Lung Cancer
Continuous Glucose Monitoring as a Driver of Quality and Value: Evidence and Perspectives from Clinical and Managed Care Leaders
The Role of TEVIMBRA® (tislelizumab-jsgr) in First-Line ESCC Treatment
Exploring Novel Treatment Options for Neurofibromatosis Type 1 With Plexiform Neurofibromas
CAR-T Cell Therapy: Navigating Access, Equity, and Operational Challenges
Effectiveness and Safety of Arimoclomol for the Treatment of Neurological Manifestations of Niemann-Pick Disease Type C: A Review of Clinical Trial Data
The Growing Role of Prescription Digital Therapeutics in the Treatment of Psychiatric Disorders
Long-Acting Injectable Administration In Schizophrenia With Insights From Genoa Healthcare® Pharmacy
Alzheimer’s Disease: Advancing Early Diagnosis and Multidisciplinary Care
Guideline-Based Strategies for the Management of Cardiovascular-Renal-Metabolic Conditions: Focus on Chronic Kidney Disease
Targeting Tear Evaporation: How Perfluorohexyloctane Ophthalmic Solution Redefines the Management of Evaporative Dry Eye Disease
Managing Obesity: Strategic Considerations for Payers
Advancing Individualized Care Approaches for Dry Eye Disease
Navigating Cutaneous Squamous Cell Carcinoma: Epidemiological Trends, Treatment Strategies, and Collaborative Care Approaches
Optimizing Management of Metastatic Colorectal Cancer: The Expanding Role of Oncology Pharmacists
The Untold Burden of Uncomplicated UTIs: Addressing Recurrence and Treatment Gaps
Exclusive Coverage of the Conference on Retroviruses and Opportunistic Infections 2025
Coverage of the Conference on Retroviruses and Opportunistic Infections, March 9-12, 2025, San Francisco, California.
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves First Oral Carbapenem Antibiotic for Complicated UTIs
2
EHA 2026 Had Something for Everyone, From Pediatric Practitioners to “Myeloma Maniacs”
3
Fourteen Years of HIV PrEP: How New Innovations Build on Decades of Progress in HIV
4
How MCOs Should Be Preparing for the OBBBA's Medicaid Cuts: David Brueggeman, MBA
5